ENDOMETRIAL CARCINOMA
Clinical trials for ENDOMETRIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL CARCINOMA trials appear
Sign up with your email to follow new studies for ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a natural compound boost chemotherapy against endometrial cancer?
Disease control Not yet recruitingThis trial is testing whether adding elemene liposomes—a compound derived from a traditional Chinese medicinal plant—to standard chemotherapy (carboplatin and paclitaxel) can help people with advanced or recurrent endometrial cancer. Participants will receive either the combinati…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
A remote diet and exercise program aims to help rural cancer survivors shed pounds and lower recurrence risk
Disease control Not yet recruitingThis trial tests whether an online, personalized lifestyle program can help rural postmenopausal breast and endometrial cancer survivors lose weight and improve their health. Participants follow a tailored diet and aerobic exercise plan, with mobile health tools to track progress…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug combo aims to stall endometrial cancer
Disease control Not yet recruitingThis phase 3 trial tests whether adding an experimental drug (GSK5733584) to standard immunotherapy can help keep advanced or recurrent endometrial cancer from growing. About 610 adults who have already completed initial chemotherapy with immunotherapy will receive either the new…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Minimally invasive surgery may offer safer option for early endometrial cancer
Disease control Not yet recruitingThis study compares two surgical approaches for early-stage endometrial cancer: laparoscopic staging (minimally invasive) and open staging laparotomy (traditional open surgery). Researchers will enroll 30 patients to see if laparoscopy is as safe and effective as open surgery, wi…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: NA • Sponsor: Ain Shams Maternity Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New targeted drug shows promise for Hard-to-Treat gynecologic cancers
Disease control Not yet recruitingThis study tests a new drug called BRY812 in people with advanced ovarian, endometrial, or ovarian clear cell cancers that have a specific marker (LIV-1). The goal is to see if the drug can shrink tumors and how safe it is. About 56 participants will receive the drug, and researc…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE2 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Aspirin may fight Cancer-Causing inflammation in the womb
Prevention Not yet recruitingThis study tests whether taking low-dose aspirin can lower inflammation in the womb lining and help prevent endometrial cancer. It involves 25 postmenopausal women who have non-atrophic endometrial changes and pain. Participants will be randomly assigned to take aspirin or not, a…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: PHASE4 • Sponsor: Mayo Clinic • Aim: Prevention
Last updated Aug 07, 2026 00:00 UTC
-
Vibrating device aims to restore bladder control in cancer survivors
Symptom relief Not yet recruitingThis pilot study tests whether a device called Flyte can help improve urinary incontinence in women who had radiation therapy for endometrial or cervical cancer. The Flyte device is used at home and delivers gentle vibrations while the user does Kegel exercises. The study will ch…
Matched conditions: ENDOMETRIAL CARCINOMA
Phase: NA • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 14:03 UTC
-
New study explores combining cancer and blood vessel surgery for advanced gynecologic tumors
Knowledge-focused Not yet recruitingThis study looks at how well patients do after surgery that removes both advanced gynecologic cancers and the major blood vessels they have grown into. Researchers will track 130 participants for up to 5 years to see survival rates and how long it takes for the cancer to return. …
Matched conditions: ENDOMETRIAL CARCINOMA
Sponsor: National Cancer Institute, Naples • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC